Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 12 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Holders of 5% or more of ANIX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Anixa Biosciences Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Kumar Amit | 13D/A | 16.30%6.17M shares | +1.20 ppfrom 15.10% | Jan 3, 20252 filings | Jun 6, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Anixa Biosciences Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 6, 20255:36 PM ET | Kumar Amit | 13D/A | 16.30%6.17M shares | +1.20 ppfrom 15.10% | Jun 4, 2025 | SEC |
| Jan 3, 20256:26 PM ET | Kumar Amit | 13D/A | 15.10%5.65M shares | – | Jan 2, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Anixa Biosciences Inc shares.
No Form 144 notices for Anixa Biosciences Inc are on file.